Lyell Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Lyell Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$273K	Sell	3,288 -11,240	-77%	-$932K	0.02%	190
2025 Q1	$1.18M	Sell	14,528 -5,566	-28%	-$451K	0.11%	110
2024 Q4	$1.81M	Sell	20,094 -973	-5%	-$87.6K	0.16%	99
2024 Q3	$2.08M	Buy	21,067 +366	+2%	+$36.2K	0.19%	96
2024 Q2	$1.92M	Sell	20,701 -1,913	-8%	-$177K	0.18%	98
2024 Q1	$2.15M	Buy	22,614 +1,892	+9%	+$180K	0.22%	92
2023 Q4	$1.85M	Sell	20,722 -783	-4%	-$69.9K	0.21%	95
2023 Q3	$1.57M	Sell	21,505 -635	-3%	-$46.4K	0.21%	94
2023 Q2	$1.84M	Sell	22,140 -5	-0%	-$416	0.24%	92
2023 Q1	$1.69M	Sell	22,145 -1,749	-7%	-$133K	0.24%	94
2022 Q4	$1.98M	Sell	23,894 -14,186	-37%	-$1.18M	0.31%	84
2022 Q3	$3.02M	Buy	38,080 +1,598	+4%	+$127K	0.51%	70
2022 Q2	$2.71M	Sell	36,482 -9,250	-20%	-$687K	0.44%	76
2022 Q1	$4.11M	Sell	45,732 -9,695	-17%	-$871K	0.53%	68
2021 Q4	$6.21M	Sell	55,427 -3,145	-5%	-$352K	0.71%	53
2021 Q3	$7.36M	Sell	58,572 -892	-2%	-$112K	0.9%	41
2021 Q2	$8.05M	Buy	59,464 +6,842	+13%	+$926K	1%	38
2021 Q1	$7.14M	Buy	52,622 +5,147	+11%	+$698K	1.04%	36
2020 Q4	$6.68M	Buy	47,475 +1,937	+4%	+$273K	1.07%	36
2020 Q3	$5.07M	Buy	45,538 +1,290	+3%	+$144K	0.95%	39
2020 Q2	$4.95M	Buy	44,248 +21,267	+93%	+$2.38M	1.09%	39
2020 Q1	$1.78M	Buy	22,981 +1,990	+9%	+$154K	0.53%	59
2019 Q4	$2M	Sell	20,991 -1,126	-5%	-$107K	0.53%	59
2019 Q3	$1.69M	Sell	22,117 -2,351	-10%	-$179K	0.51%	58
2019 Q2	$2.15M	Buy	24,468 +2,812	+13%	+$247K	0.65%	53
2019 Q1	$1.96M	Buy	21,656 +4,926	+29%	+$446K	0.65%	53
2018 Q4	$1.2M	Buy	16,730 +1,635	+11%	+$117K	0.5%	58
2018 Q3	$1.45M	Buy	15,095 +2,906	+24%	+$279K	0.49%	60
2018 Q2	$1.16M	Buy	12,189 +2,806	+30%	+$267K	0.42%	68
2018 Q1	$823K	Buy	9,383 +115	+1%	+$10.1K	0.3%	72
2017 Q4	$787K	Buy	9,268 +2,413	+35%	+$205K	0.31%	75
2017 Q3	$593K	Buy	+6,855	New	+$593K	0.26%	77